ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 749,57
-0,22%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. GlycoMimetics Inc (GLYC)

  7. GlycoMimetics Inc (GLYC) Actualités

GLYC GlycoMimetics Inc

1,8399
0,1199 (6,97%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
GlycoMimetics Inc GLYC NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,1199 6,97% 1,8399 06:00:05
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,67 1,63 1,84 1,83 1,72
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
25/4/202413:00BWGlycoMimetics to Report First Quarter 2024 Financial Results..
27/3/202412:00BWGlycoMimetics Reports Highlights and Financial Results for..
13/3/202412:00BWGlycoMimetics to Report Fourth Quarter and 2023 Full Year..
01/3/202415:16EDGAR2Form 8-K - Current report
26/2/202413:00BWGlycoMimetics to Participate in Upcoming Cowen 44th Annual..
12/2/202413:00BWGlycoMimetics Reports Inducement Grant Under NASDAQ Listing..
17/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202413:00BWGlycoMimetics Announces Positive Initial Safety and..
03/1/202413:00GLOBEApollomics Completes Enrollment in Phase 3 Bridging Study of..
02/1/202422:30EDGAR2Form 8-K - Current report
02/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202318:00BWGlycoMimetics Announces Independent Presentations on..
09/11/202313:00BWGlycoMimetics to Participate in Upcoming Jefferies London..
03/11/202313:35EDGAR2Form 8-K - Current report
03/11/202313:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202312:00BWGlycoMimetics Reports Highlights and Financial Results for..
23/10/202314:30PRNUSAnixa Biosciences Appoints Accomplished Medical Oncologist..
20/10/202313:00BWGlycoMimetics to Report Third Quarter 2023 Financial Results..
03/10/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/9/202322:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202313:00BWGlycoMimetics Announces First Cohort Dosed in Human Phase 1a..
05/9/202313:00BWGlycoMimetics to Participate in Upcoming H.C. Wainwright..
17/8/202313:00BWGlycoMimetics Reports Inducement Grant Under Nasdaq Listing..
02/8/202314:35EDGAR2Form 8-K - Current report
02/8/202314:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/8/202313:00BWGlycoMimetics Reports Highlights and Financial Results for..
19/7/202313:00BWGlycoMimetics to Report Second Quarter 2023 Financial..
26/6/202314:00BWGlycoMimetics Announces Its Addition to the Russell..
15/6/202314:00BWGlycoMimetics Announces U.S. Food and Drug Administration..
31/5/202313:00BWGlycoMimetics to Participate in Upcoming Jefferies 2023..

Dernières Valeurs Consultées

NASDAQ
GLYC
GlycoMimetics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés